ImpriMed
CompanyUnited States· Diagnostics
Palo Alto precision medicine company that uses AI to predict how cancers respond to drugs.
Minutes holds 1 development and 1 deal naming ImpriMed, recorded from September 2026.
Intelligence
Investors in rounds covered by Minutes
Deals in Minutes
| Company | Deal | Amount | Counterparties | Date ↓ | Status |
|---|---|---|---|---|---|
| ImpriMedDiagnostics | FundingSeries A2 bridge round | $10M | Led by LB InvestmentWith NAVER D2SF, Samsung Securities +3 | 18 Sep | Closed |